{"name":"ImmVira Pharma Co. Ltd","slug":"immvira-pharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPdWpfRE9DNFBKQTFKRXZxU19sY0tFVnM0NGFfVjRTdkxSSDY5OW9fRzZEMjhMWEE2Vkp2S1dha3RjZU1xTVBhcENZbjE2aHRMTW5iU0tydFRKSUREWHBHRUwzWWxVTGQxRjAza1BJaktUTFNtaUE4allvLU14WU0ybWZSMm9zOXVEVnNWY1Y4ckFRajlUendLZU1LSUZFbTZ6VTRpN2ZNYkUzRHFLdlZWakZ2bjZiX18xRVIzYjNRNld5QmQ2cEdqYWswdHJCVzk3Y0s5YS1DYVZwbVlGb1NvMmpvUjNQamhhaEx1SGlGeXdyRUN0SlhvbkJjYkF2dTd4bTktWFZOalQtRTJiTVVOampJZmVNOEV2eG1MV1pXWEpYRlduMWpZSnFnVTVHSWE2TjV4YVhCN2JIX1Z1dkFTZVpqblA5endudkRoeHRDdTdzZw?oc=5","date":"2026-03-25","type":"pipeline","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - B","headline":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPUi1PZTA4RnhTUU1RUmRITlpoZGZCaFp6ZEZEYS1HdTQ5V1pWUFNIWC1LVWpYaDRfRWxHRkE0RGNXcDhOUUN4NHY0bXV3dUdNOWoyMGoyZzJxbEszdFF1Zm9Jc2QxeHR0OHR6djBNeHRnTWZ4VmNTWms1dUNCRDFXRkdudEpaZ240ZVR0TG05eW1URS0wdzI4Um9pMDIzTU9pQWJIRklodUY0MGh6NGNlanZ3dXUzdjNsN0hDU0JpUU8yS1V2RV9IWGtJVEhfRVMtQXp1TVB0SFgyLU1hVnE4UjJYcVV3MmcyNV9sQUMxVUg1TTNadkN0Tzl1anN1aVgtY3dXLWQtam1kMXRoQS1XVlVLMUhjUQ?oc=5","date":"2026-03-25","type":"trial","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering N","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPZDg1Z01CSUR6V0pPTkdnYmFaNEE3NzA1US03VWZJLTg3Y05FTWVpZ0MwS2xaVEFhSXFLMElZbmtrdzUxbEpFTHdiNzBKZDN6enJiZWdLV2tNQjRPaU5qcVJmN0luRlFFNEF1R01nWXVreTl5SUszaDgtNkVtcUx5WFhzUkcyeWk2M1ZrRWUxcERobWZVOTkxTmdadi05Zw?oc=5","date":"2026-03-11","type":"trial","source":"openPR.com","summary":"Advanced Liver Cancer Clinical Trial Pipeline Shows Potential - openPR.com","headline":"Advanced Liver Cancer Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOQTR0d1l3a3B2VmdFdjY0QkJVZ01rYmtPV0gtNERtMXMyN1lXdTdpOTFRRjFjREFaSENvbDByU2JUdzRVZ2Mxc3dsbU8zYm5MUElhVGl3RHkyU3NzaTZ5b3U2T1NOUGlUaE90MDNtUTB1Z2xIeWRSZ1NfTEpwU1hzcDZiZnpYX0puU1lTZmYyMDZ6YS02YnowdU1jbU1wZmh0d3pYNmpiYV9VVnpzTXRva09wdE9RUzZ1d3dWOGtVMGJwVmFaVkJndlJMM09oSWRhUWZKVUJJSW1iSXBWc0p5bm83ZlZOYmxaZXdEOG1ZZHZib2pxcUltWmFrdjJha0JhRFNKYTF3QlFjd0hEN29VTVJB?oc=5","date":"2026-02-04","type":"trial","source":"PR Newswire","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - PR Newswire","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigANBVV95cUxOLVNNUl9QMEhFQkZZWm4xdkUybGVUalhwWkFaNzVVT3NSdldmMko0b2trN00tbjZ4S2dpbDVBLWhOWmtpRm5YcDk3QXQ1ZXA1QzZHMjJfTFd1alVQMGE4NkE0eDc5LWxaR19DeEtkbGl2b3dlWkx6NFhFY2pFZnA4empTTXhHalV1UTBsR3Q4WkJRaHkyZjJsYkNSN1l2Q3l4VXR6XzFRZmZ3X2ctMDdQUk11MmtRQ0N0RWkxSGpGVDlKMTI3N1hzTGdqc0EtcTc2eVZBS0VHWm5RTDA5X3diZGxMbFB5OGt0SEtKQUQzRzlJcE84V2pXdGQwUkJ6aklKX1RfMXFNMWVkaXN1WkN4TWltOGhORkRDNTlLQTduZjIzbXhfcGI1V3dvVXdmNzVyQ2huRmJwbERQQVZ2dkFiMV9oQ1padVVqOG5BWVEyMGJrUjI3aGVITDdldlRqekQ0T2NiWlZGVm1kdDFLdENCV2dvel9HME5HVFBPUkk0Nzg?oc=5","date":"2025-06-10","type":"trial","source":"PR Newswire","summary":"ImmVira Announces First Patient Dosed in a Multi-Regional Phase II Clinical Trial Evaluating MVR-T3011 Oncolytic Immunotherapy in Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder C","headline":"ImmVira Announces First Patient Dosed in a Multi-Regional Phase II Clinical Trial Evaluating MVR-T3011 Oncolytic Immunot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNdFRjdndDbVVKWFNHRzVwODV6RlJmY2hvVHlST3k3NUdZWmFSMjQweG9DRWRyZHRvZGlHdUtXamFHNC1leC1pNVpsb0pmMEFiUlVycDEtMXdjbzhGRTdDVWtNLVQyN0JNS3R3dlBPWTBBMzJ2MlRmZFVsc1QwRDhHakpVWHp5ZXBqUmpFWXJmeU5lU1Y0Q0RVVUQtQk5FRUEwcG5hcll1Ym1Gb1VxUUFEa1NwdEk2Y0wzSWZmVUxWYXNuNlBpbnRNbkZwN2lmSHpVZ1ZIVlZUVmRHcVJTeExTTWhjX0xOOXBHMVJHYmlHTkkwbGM4RElFVDlaX1BEdUdmZnp6SHUxbjJzbnQyVEdHbzlpVGo5QnpNOVE?oc=5","date":"2020-08-06","type":"deal","source":"marketscreener.com","summary":"Shanghai Pharmaceuticals : ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies - marketscreene","headline":"Shanghai Pharmaceuticals : ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commerc","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}